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Background: MicroRNAs are a class of small non-coding RNAs that play an important role in various human tumor
initiation and progression by regulating gene expression negatively. The aim of this study was to investigate the
effect of miR-214 on cell proliferation, migration and invasion, as well as the functional connection between miR-
214 and PTEN in gastric cancer.
Methods: miR-214 and PTEN expression was determined in gastric cancer and matched normal tissues, and human
gastric cancer cell lines by quantitative real-time PCR. The roles of miR-214 in cell proliferation, migration and
invasion were analyzed with anti-miR-214 transfected cells. In addition, the regulation of PTEN by miR-214 was
evaluated by Western blotting and luciferase reporter assays.
Results: miR-214 was noted to be highly overexpressed in gastric cancer tissues and cell lines using qRT-PCR. The
expression level of miR-214 is significantly associated with clinical progression and poor prognosis according to the
analysis of the clinicopathologic data. We also found that the miR-214 levels are inversely correlated with PTEN in
tumor tissues. And PTEN expression level is also associated with metastasis and invasion of gastric cancer. In
addition, knockdown of miR-214 could significantly inhibit proliferation, migration and invasion of gastric cancer
cells. Moreover, we demonstrate that PTEN is regulated negatively by miR-214 through a miR-214 binding site
within the 3’-UTR of PTEN at the posttranscriptional level in gastric cancer cells.
Conclusions: These findings indicated that miR-214 regulated the proliferation, migration and invasion by targeting
PTEN post-transcriptionally in gastric cancer. It may be a novel potential therapeutic agent for gastric cancer.
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Gastric cancer is the second most common cause of
cancer-related death worldwide. It has been estimated
that approximately 1 million patients are newly diag-
nosed with gastric cancer worldwide each year, which
accounts for nearly 10% of all cancer deaths and claims
approximately 700,000 lives annually [1,2]. Gastric can-
cer is a complex genetic disease, previous studies have
demonstrated that several genes, known as oncogenes or
tumor suppressors, were related to the initiation and
progression of human gastric cancer [3], but the com-
mon molecular mechanisms of gastric cancer remain to
be elucidated.* Correspondence: songzhenshun@yahoo.com.cn
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reproduction in any medium, provided the orMicroRNAs, a class of small non-coding 18–25 nt in
length RNAs, have been identified that it aberrantly
expressed in several human malignancies, and could
negatively regulate target gene expression by binding to
the 3’-untranslated region (3’-UTR) of mRNAs for trans-
lational repression or degradation [4,5]. In the recent
years, mounting evidence suggest that microRNAs plays
a essential roles in tumor cell biological processes, such
as cell proliferation, differentiation, migration and inva-
sion [6-9].
A recent study determined the relationship between
miRNA expression and progression of gastric cancer,
which showed that 22 microRNAs were up-regulated,
and 13 were down-regulated in gastric cancer, including
miR-214 [10]. However, the specific role and molecular
mechanism of miR-214 in gastric cancer cells remains un-
known. Thus, we investigated the relationship betweend. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and prognosis in gastric cancer, and further studied the
possible function of miR-214 in the gastric cancer cell line.
Our study results show that overexpression of miR-214 is
significantly associated with metastasis and invasion and
poor prognosis in gastric cancer, moreover, it could nega-
tively regulates PTEN by binding to their 3’-UTR regions
to affect gastric cancer cell proliferation, migration and
invasion.Materials and methods
Human tissue samples and cell lines
Human tumor tissue samples and adjacent noncancerous
controls were obtained by surgical resection from 120
patients with gastric cancer, at Department of General
Surgery, Tenth peoples’ hospital, School of Medicine,
Tongji University, Shanghai, China. All samples were
derived from patients who had not received adjuvant
treatment including radiotherapy or chemotherapy prior
to surgery. All samples were snap-frozen and stored in
liquid nitrogen after collection. Written informed consents
were obtained from all subjects, and the study was
approved and supervised by the Ethics Committee of
Shanghai Tongji university.
The human gastric cancer cell lines SGC-7901, BGC-823
and normal gastric mucosa epithelial cell lines GES-1 were
purchased from the Shanghai Institute of Biochemistry
and Cell Biology (Shanghai, China). Cells were maintained
in RPMI1640 (Invitrogen, US) supplemented with 10%
fetal bovine serum (Invitrogen, US). All cells were incu-
bated at 37°C in a humidified chamber supplemented with
5% CO2.RNA extraction and quantitative PCR
Total RNA from tissue sample and cells were isolated
using TRIzol reagent (Invitrogen, US). The relative levels
of miR-214 were examined by the altered stem-loop
RT-PCR with specific RT and PCR primers using U6
snRNA as control. The primers for miR-214 were: Forward
primer: 5’-AGCATAATACAGCAGGCACAGAC-3’; Re-
verse primer: 5’-AAAGGTTGTTCTCCACTCTCTCAC-3’.
The expression of PTEN mRNA were detected by quanti-
tative PCR using paired primers. β-actin gene was used as
control. The primers for PTEN mRNA were: Forward pri-
mer: 5’-ACCAGTGGCACTGTT GTTTCAC-3’; Reverse
primer: 5’-TTCCTCTGGTCCTGGTATGAAG-3’.
Quantitative PCR was performed on MX3000P Real-time
PCR Instrument (Stratagen, US) using Real-time PCR
Universal Reagent (GenePharma, Shanghai) according
to the manufacturer’s instructions. The relative expres-
sion levels of interest gene were calculated by the 2-ΔΔCt
method.Cell transfection
1×106 cells cultured in a well of 6-well cell culture plate
were transiently transfected with 50 pmol of miR-214
inhibitor (or control microRNA) and PTEN siRNA
oligonucleotide duplexes (or control siRNA) using
Lipofectamine 2000 (Invitrogen, US) according to the
manufacturer’s protocol, respectively. The sequence
used were: 5’-ACUGCCUGUCUGU GCCUGCUGU-3’
(miR-214 inhibitor oligonucleotide); 5’-CAGUACUUU
UGUGUAGUAC AA-3’ (control oligonucleotide). Vali-
dated siRNAs directed against PTEN and control siRNA
were obtained from Cell Signaling. Transfection effi-
ciency was optimized using 6-carboxyfluorescein la-




bromide (MTT) assay to determine the viability of cells.
Cells were seeded in 96-well plates at 8000 cells per well.
At the end, cells were incubated in 50 ml of 0.1 mg/ml
solution of MTT at 37°C for 4 h and then lysed in 150 ml
of dimethylsulfoxide at room temperature for 15 min.
Viable cell numbers were estimated by measurement of
optical density (OD) at 580 nm at various time points.
Cell population doubling time and cell cycle assay
Cell population doubling time calculation and cell
cycle assay were performed as previously described
[11]. Cells were seeded into 6-well plates (1 × 104 cells/
well) and cultured at 37°C. Cell population doubling
time (PDT) was calculated using the following equa-
tion: PDT (hr) = (log2×t)/(logNt-logN0), where t=time
in culture (hr), Nt = final cell count, N0 = original cell
count.
In the cell cycle assay, Cells were fixed in 70% ethanol
for 2 hr at 4°C, then, the cells were treated with RNaseA
(50 μg/ml) and stained with propidium iodide (25 μg/ml)
for 30 min at 37°C. Analyzed all samples using an
FACSCalibur flow cytometer (BD Biosciences) and
distribution of cell-cycle phases was determined using
Modfit Software (BD Biosciences). The proliferative
index (PI) was calculated as the percentage of cells in S/
G2/M-phase.
Clonogenic assay
Clonogenic assay was also performed as previously de-
scribed [12]. Single-cell suspension was prepared using
trypsin treatment. Cells were then seeded into 6-well cell
culture plates (200 cells/well) and incubated for 14 days
at 37°C. Then, cells were washed twice with PBS and
stained with a mixture of 6.0% glutaraldehyde and 0.5%
crystal violet for 1 hour at 37°C. The plates were air
dried at room temperature. Colony forming efficiency
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that formed colonies.
Cell migration and invasion assay
A cell suspension of in 0.2 ml RPMI-1640 medium with
5% FBS was seeded into each well of the upper Transwell
chamber (8-μm pore size, Corning Costar Corp, US),
which was pre-coated with or without Matrigel. In the
lower chamber, 0.6 ml RPMI 1640 with 20% FBS was
added. After incubating for 28 h 37°C in a humidified
incubator with 5% CO2, chambers were disassembled and
the membranes were stained with 2% crystal violet for
10 min and placed on a glass slide. The number of cells
penetrating across membrane were counted under a
microscope in ten random visual fields.
Luciferase reporter assay
Dual-luciferase activity assays were performed as previ-
ously described [7]. The full-length 3’-UTR segments of
PTEN mRNA containing the miR-214 binding site was
amplified by PCR and inserted into the Xba1-site of pGL3
vector (Promega, WI) and named pGL3-PTEN. The
pGL3-PTEN-mut reporter construct with point mutations
in the seed sequence was synthesized using a site-directed
mutagenesis kit (Stratagene, CA). Then, 1 × 106 cells were
cotransfected with 50 pmol of miR-214 inhibitor (or con-
trol miRNA), 1 μg of pGL3-PTEN (or pGL3-PTEN-mut)
plasmid, and 1 μg of a Renilla luciferase expression con-
struct pRL-TK (Promega, WI) using Lipofectamine 2000.
After 36 h transfection, luciferase activity was measured
using the dual luciferase assay system (Promega, WI) and
normalized to Renilla luciferase activity.
Western blotting
Cells were washed twice with Hanks’s balanced salt solu-
tion and lysed directly in lysis buffer (50 mM Tris–HCl,
pH 8.0, 1% NP-40, 10 mM NaCl, 2 mM EDTA, 5 mg/ml
leupeptin, 2 mg/ml aprotinin, 2 mg/ml pepstatin, 1 mM
DTT, 0.1% SDS and 1 mM phenylmethylsulfonyl fluoride).
The protein concentrations of the lysates were measured
using a Bradford protein assay kit (Bio-Rad, US). Equiva-
lent amounts of protein were separated by 10% SDS PAGE
and then transferred to nitrocellulose membranes by
electroblotting. The membranes were blocked with 5%
BSA in TBST (10 mM Tris–HCl, pH 8.0, 150 mM NaCl,
and 0.05% Tween 20) for 1 hr, and then the membrane
was immunoblotted overnight at 4°C with primary anti-
body, a secondary antibody conjugated with horseradish
peroxidase was incubated with the membrane for 1 hr at
37°C. Protein was visualized using enhanced chemilumin-
escence reagent (Santa Cruz). The expression level of
PTEN protein was analyzed using LabWork 4.0 program
(UVP) and normalized to that of β-actin protein.Statistical analysis
Data are presented as mean ± SEM from at least three
independent experiments. Statistical significance was an-
alyzed using SPSS11.0 software package (SPSS Inc., US).
The difference between groups was performed with Stu-
dent’s t-test. Pearson’s correlation was used to estimate
the relationship between expression levels of miR-214
and PTEN mRNA. Survival curves were obtained by the
Kaplan-Meier method, comparison between curves was
calculated by Log-rank test. Differences were considered
significant for p-values less than 0.05.Results
The expression level of miR-214 is up-regulated and
inversely correlated with PTEN mRNA in gastric cancer
tissues
The quantitative RT-PCR detection results showed that
the expression levels of miR-214 were significantly higher
in gastric cancer cell lines in comparison with the normal
gastric mucosa epithelial cell lines (Figure 1A). In the
meantime, miR-214 overexpression is also observed in
gastric cancer tissues compared to normal gastric mucosa
tissues (Figure 1B). Furthermore, the expression of miR-
214 is significantly associated with invasion, metastasis
and TNM stage according to the clinicopathologic data
from the gastric cancer patients (Table 1), and clinical
relevance was confirmed by the observation that miR-214
overexpression correlated with poor prognosis (Figure 1F).
All these evidence indicated that miR-214 may be involved
in gastric cancer carcinogenesis.
We also examined the expression levels of PTEN
mRNA in gastric cancer tissues and normal gastric mu-
cosa tissues. Our results showed that decreased expres-
sion of PTEN mRNA was found in gastric cancer
tissues (Figure 1C). Furthermore, we found that PTEN
mRNA expression was significantly associated with me-
tastasis and TNM stage (Table 1). Across all specimens
tested, we found an inverse correlation between the
expression of miR-214 and the level of PTEN mRNA
(Figure 1D, r=−0.349, P=0.027), but not in normal tis-
sues (Figure 1E, r=−0.026, P=0.641). These data suggest
that miR-214 may be involved in the regulation of
PTEN in gastric cancer.Knockdown of miR-214 could inhibit the proliferation,
migration and invasion of gastric cancer cell lines
We firstly investigated the effect of miR-214 on prolifer-
ation of BGC-823 gastric cancer cell lines using MTT
assay. As shown in Figure 2A, MTT value of cells
transfected with anti-miR-214 was significantly lower
than that of cells transfected with control anti-miRNA
after 48 hr post-transfection. In addition, cells treated
with anti-miR-214 had a significantly longer population
Figure 1 Expression of miR-214 and PTEN in gastric cancer cell and tissue specimens. Detection of miR-214 and PTEN mRNA by qRT-PCR
using U6 snRNA for normalization. Both SGC-7901 and BGC-823 cells express higher levels of miR-214 compared with normal gastric mucosa
epithelial cell lines GES-1 (A), the expression of miR-214 in gastric cancer tissues is higher than that in normal gastric mucosa tissues (B). Whereas,
the expression of PTEN mRNA in gastric cancer tissues is lower than that in normal gastric mucosa tissues (C), in addition, we found an inverse
correlation between the expression of miR-214 and the level of PTEN mRNA in gastric cancer tissues, but not in normal tissues (D, E). Kaplan-
Meier survival curves for 120 gastric cancer cases, low expression of miR-214 (red) was defined as long survival, and high expression (green) was
defined as short survival (F). *P < 0.05; **P < 0.01.
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forming efficiency than cells transfected with control
anti-miRNA (Figure 2B-F). Meanwhile, it showed that
cell number migrating across the membrane with or
without matrigel of cells transfected with anti-miR-214was significantly less than that of cells transfected with
control anti-miRNA (Figure 2G-H). These results pro-
vide strong evidence that knockdown of miR-214 could
inhibit the proliferation, migration and invasion of
gastric cancer cells.
Table 1 Association of PTEN mRNA or miR-214 expression with clinicopathological data from gastric cancer patients by
quantitative PCR
Variable N miR-214 PTEN
Relative expression level p-value Relative mRNA level p-value
Age (years)
≤ 60 47 3.429±1.924 0.117 0.374±0.238 0.717
> 60 73 4.384±1.317 0.769±0.225
Tumor size
≤ 4 cm 67 3.954±1.499 0.101 0.809±0.229 0.060
> 4 cm 53 4.762±1.252 0.667±0.187
Borrmann’s Classification
I-II 65 4.168±1.231 0.789 0.748±0.230 0.608
III-IV 55 4.298±1.821 0.787±0.219
Lauren’s Classification
Intestinal 64 3.984±1.579 0.416 0.724±0.261 0.377
Diffuse 56 4.372±1.385 0.789±0.198
Invasive depth
T1-T2 52 2.927±1.749 0.001
* 0.826±0.301 0.310
T3-T4 68 4.647±1.070 0.741±0.195
Metastasis
Negative 76 4.006±1.359 0.005* 0.788±0.219 0.031*
Positive 44 6.105±0.913 0.535±0.122
TNM staging
I-II 57 3.367±1.361 0.001* 0.843±0.215 0.047*
III-IV 63 4.845±1.205 0.704±0.163
*significantly different.
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expression by targeting the 3’ untranslated region of
PTEN
It was reported that the 3’-UTR of PTEN contains the
miR-214 target sequence [13]. To investigate whether
miR-214 directly can alter the expression of PTEN in
gastric cancer cells, a fragment of the 3’-UTR of PTEN
mRNA, containing the putative miR-214 binding se-
quence, was cloned into a firefly luciferase reporter
construct, and cotransfected with a control Renilla
luciferase reporter construct into gastric cancer cells
along with either anti-miR-214 or control anti-miRNA.
As shown in Figure 3A, BGC-823 and SGC-7901 cell
lines cotransfected with anti-miR-214 and pGL3-PTEN
plasmid showed a significant increase of reporter activity
in comparison with those cotransfected with the control
anti-miRNA and pGL3-PTEN plasmid. However, cells
cotransfected with anti-miR-214 and pGL3-PTEN-mut
plasmid showed no significant difference in reporter activ-
ity as compared with cells cotransfected with control anti-
miRNA and pGL3-PTEN-mut plasmid (Figure 3B).
We further determined the expression of PTEN protein
and mRNA by Western blotting and qRT-PCR in gastriccancer cells transfected with anti-miR-214 (or control
anti-miRNA). As shown in Figure 3C and 3D, the ex-
pression of PTEN protein was significantly increased in
cells transfected with anti-miR-214 as compared to the
cells treated with control anti-miRNA at 48 hr post-
transfection. However, the expression of PTEN mRNA
showed no significant difference between the two
groups (Figure 3E). These results indicate that the 3’-
UTR of PTEN mRNA is a functional target of miR-214
in gastric cancer cells.
Down-regulation of PTEN could significantly attenuated
the inhibitory effects of anti-miR-214 on the proliferation,
migration and invasion of gastric cancer cell lines
To further evaluate the contribution of PTEN to biological
effects of miR-214, we assessed the impact of PTEN silen-
cing by RNA interference, and hence PTEN expression on
anti-miR-214 dependent cell proliferation, migration and
invasion in BGC-823 gastric cancer cell lines. At 48 hr
posttransfection, Western blotting revealed that the ex-
pression level of PTEN in cells cotransfected with anti-
miR-214 and PTEN siRNA plasmid was significantly lower
than that in cells cotransfected with anti-miR-214 and
Figure 2 (See legend on next page.)
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Figure 2 Down-regulation of miR-214 inhibits the proliferation, migration and invasion of BGC-823 gastric cancer cell lines. (A) Cell
viability was measured at 24 hr post-transfection by MTT assay. Results showed that MTT value of cells transfected with anti-miR-214 was
significantly lower than that of cells transfected with control anti-miRNA after 48 hr post-transfection. (B) Cell population doubling time (PDT) was
determined as described in materials and methods with cells at 24 hr post-transfection. Results showed that the PDT of cells transfected with
anti-miR-214 was significantly longer than that of cells transfected with control anti-miRNA. (C, D) Cell cycle analysis was performed at 48 hr post-
transfection by staining DNA with propidium iodide prior to flow cytometry. Results showed that proliferative index (PI) of cells transfected with
anti-miR-214 was significantly lower than that of cells transfected with control anti-miRNA. (E, F) Clonogenic assay was performed as described in
materials and methods with cells at 24 hr post-transfection. Results showed that the colony forming efficiency (CFE) of cells transfected with anti-
miR-214 was significantly lower than that of cells transfected with control anti-miRNA. (G, H) Gastric cancer cells transfected with anti-miR-214
and control anti-miRNA were seeded into the upper part of a transwell chamber with or without matrigel, cells migrating across the membrane
were counted in all fields. Results showed that number migrating across the membrane with or without matrigel of cells transfected with anti-
miR-214 was significantly less than that of cells transfected with control anti-miRNA. Data represent mean ± SEM from three independent
experiments; *P < 0.05 by t test, **P < 0.01 by t test.
Figure 3 miR-214 post-transcriptionally regulates PTEN expression by targeting the 3’-UTR of PTEN. (A, B) Luciferase reporter assay were
performed at 48 hr post-transfection. BGC-823 and SGC-7901 gastric cancer cell lines were transfected respectively with the Renilla luciferase
expression construct pRL-TK and pGL3-PTEN-3’-UTR firefly luciferase expression construct, along with either anti-miR-214 or control anti-miRNA.
Results showed that cells co-transfected with miR-214 and pGL3-PTEN plasmid exhibited a significant increase of reporter activity in comparison
with those co-transfected with the control anti-miRNA and pGL3-PTEN plasmid. However, the reporter activity of cells co-transfected with anti-
miR-214 and pGL3-PTEN-mut plasmid showed no significant difference with that of cells cotransfected with control microRNA and pGL3-PTEN-
mut plasmid. (C, D) The expression level of PTEN protein was detected by Western Blot at 48 hr post-transfection and normalized to that of
β-actin. Results showed that the level of PTEN protein was significantly increased in cells transfected with anti-miR-214 as compared to the cells
transfected with control anti-miRNA. (E) The expression level of PTEN mRNA was detected by qRT-PCR at 48 hr posttransfection and normalized
to that of GAPDH. Results showed that the expression level of PTEN mRNA exhibited no significantly difference between cells transfected with
anti-miR-214 and those transfected with control anti-miRNA. Data represent mean ± SEM from three independent experiments; *P < 0.05 by
t test, **P < 0.01 by t test.
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Figure 4 Down-regulation of PTEN attenuates the effects of anti-miR-214 on BGC-823 gastric cancer cell proliferation, migration and
invasion. (A, B) The expression level of PTEN protein was detected by Western-blot at 48 hr post-transfection and normalized to that of β-actin.
Results showed that the expression level of PTEN protein was significantly lower in cells co-transfected with anti-miR-214 and siRNA-PTEN as
compared to the cells transfected with anti-miR-214 and control siRNA. Cell vability was detected by MTT assay (C), population doubling time
determination (D), proliferative index (E), clonogenic assay (F), migration and invasion assay (G, H) as described in materials and methods. Results
showed that the proliferative capacity of cells co-transfected with anti-miR-214 and siRNA-PTEN was significantly higher than that of cells co-
transfected with anti-miR-214 and control siRNA. Data represent mean ± SEM from three independent experiments; *P < 0.05 by t test, **P < 0.01
by t test.
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showed that the effect of anti-miR-214 in decreasing both
cell proliferation, migration as well as cell invasion wasprevented by the presence of siRNA to PTEN in gastric
cancer cell lines (Figure 4C-H). These results indicated that
down-regulation of PTEN expression could significantly
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eration, migration and invasion, suggesting that the anti-
miR-214 inhibits the proliferation, migration and invasion
of gastric cancer cells through the PTEN-mediated
signal pathway.
Discussion
Recent several studies shown the dysregulation of some
miRNAs in various types of human cancers, and the
alteration of miRNAs expression might contribute to
human carcinogenesis by regulating multiple types of
target genes expression [13-15]. Hence, identification of
specific miRNAs and their targets involved in tumorigen-
esis would provide valuable insight for the diagnosis and
therapy of patients with human malignancies. Here, we
have demonstrated that knockdown of miR-214 could in-
hibit proliferation, migration and invasion capacity of gas-
tric cancer cells by negatively regulating tumor suppressor
PTEN at the post-transcriptional level via binding to
non-coding regions of PTEN. Our study data suggest
that miR-214 may be useful as a novel potential thera-
peutic approach for the treatment of gastric cancer.
It was previously reported that miR-214 is involved in
the murine aging process [16], modulates Hedgehog sig-
naling to specify muscle cell fate [17], and induces cell
survival and cisplatin resistance by targeting PTEN in
human ovarian cancer [7]. In addition, miR-214 expression
was elevated in pancreatic cancer tissues compared with
matched benign pancreatic tissues, and overexpression of
miR-214 could decreased the sensitivity of the pancreatic
cancer cells to gemcitabine by targeting ING4 mRNA [18].
Meanwhile, miR-214 is down-regulated in human cervical
cancer tissue compared with normal tissue and that it
negatively regulates HeLa cell proliferation by targeting
the noncoding regions of MEK3 and JNK1 mRNAs [19].
In the present study, we found that the expression level of
miR-214 was up-regulated in gastric cancer tissue com-
pared with matched normal tissue, and miR-214 expres-
sion level was significantly associated with clinical
progression and poor prognosis. Specially, we found that
the proliferative, migratory and invasive capacity of gastric
cancer cells transfected with anti-miR-214 was signifi-
cantly lower than that of cells transfected with control
anti-miRNA, suggesting that repressing miR-214 expres-
sion could inhibit the proliferative and progressive cap-
acity of gastric cancer cells.
PTEN is a protein tyrosine phosphatase and tensin
homologue, which was first discovered by independent
laboratories and identified as a tumor suppressor gene
located on human chromosome region 10q23 [20]. It
has been reported that PTEN makes a great contribution
to cellular apoptosis, proliferation, migration and inva-
sion, as well as angiogenesis through interference with
several signaling pathways [21-24]. Recent studies haveshown that PTEN protein expression frequently is de-
creased or absent in human gastric cancer. Moreover,
decreased PTEN expression correlates with differenti-
ation, growth, progression and angiogenesis in gastric
cancer [25,26]. In addition, up-regulation of PTEN can
increase expression of Caspase-3 to make tumor cells
apoptosis disorder, which forms molecular mechanisms
of PTEN contribution to tumorigenesis and progression
of gastric cancer [27].
In this study, we confirmed that PTEN is down-
regulated in gastric cancer in vivo, consistent with the
previous findings. Moreover, the expression of PTEN is
positively correlated with metastasis and invasion from
the clinicopathologic data analysis. In addition, we ob-
served a highly significant negative correlation between
miR-214 and PTEN expression in tumor tissues,
suggesting that miR-214 could be involved in the regu-
lation of PTEN in gastric cancer. Combining with the
target reporter assays, we further have demonstrated
that miR-214 post-transcriptionally regulates PTEN via
binding the 3’-UTR of PTEN mRNA. Considering the
different miRNA have different roles and target genes in
different tumors, so we have choosed two gastric cancer
cell lines as a model to validated the regular effects of
miR-214 on PTEN gene.
In summary, we have demonstrated that miR-214 is
overexpressed in gastric cancer, and knockdown of miR-
214 can significantly inhibit the proliferation, migration
and invasion capacity of gastric cancer cell through the
PTEN-mediated signal pathway, which has not been
documented in previous studies. Our data suggest that
miR-214 is possible to become a potential therapeutic
agent for gastric cancer.
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